Update information

Update information

October 2018: A correction was made to table 2. The treatment for Lyme carditis in children aged 9 to 12 who are haemodynamically unstable was changed to intravenous ceftriaxone, and the first alternative was changed to oral doxycycline. A footnote was also added on using clinical judgement to determine doses of doxycycline in children under 12 years with severe infections.

Minor changes since publication

October 2018: The weight limit for calculating doses of intravenous ceftriaxone in children under 12 was amended in table 2.

July 2018: A correction was made to table 2 for the duration of treatment for Lyme arthritis or acrodermatitis chronica atrophicans in children aged 9 to 12 with a severe infection. Maximum doses for intravenous ceftriaxone treatment in children under 12 were also added.

May 2018: The definition for the Jarisch–Herxheimer reaction was amended to clarify when the reaction can start.

ISBN: 978-1-4731-2919-1

  • National Institute for Health and Care Excellence (NICE)